Sabitlenmiş Tweet
Let’s Fight Bladder Cancer, Scotland! @BladderCancerUK @NHS_Lothian @NHS_HS #BladderCancer #BladderCancerAware
English
Prof Param Mariappan FRCS(Urol), PhD
2.8K posts
Prof Param Mariappan FRCS(Urol), PhD
@ParamMariappan
Consultant Urological Surgeon | Director Edinburgh Bladder Cancer Surgery @EdinSurg_BC | @Uroweb Bladder Cancer Guideline panels | Golfer. Views my own
Edinburgh, United Kingdom Katılım Nisan 2019
955 Takip Edilen1.4K Takipçiler
Prof Param Mariappan FRCS(Urol), PhD retweetledi
Which is exactly why we at @IBCG_BladderCA [and @sitcancer] have maintained that TaHG should be classified as high risk.
Because the clinical outcomes, molecular biology, progression patterns, all point in the same direction.
High-grade biology matters more than arbitrary cutoffs; a TaHG tumor does not suddenly become biologically “intermediate risk” because it is 2.95 cm versus 3.02 cm
Classification is not semantics. Classification drives treatment. And treatment drives outcomes. @BladderCancerUS @WorldBladderCan
English
Prof Param Mariappan FRCS(Urol), PhD retweetledi
Manchester #radbio represented at #ESTRO26 with honorary biologist @janeshortall1- the red T-shirts are special! @RT_physics @ESTRO_RT #BioCommittee @MCRCnews
English
Another great day out in #Edinburgh!
Marking our 8th #BCAM walk with the first ever BCAM Spacehopper race 😃
Many thanks to all who attended.
(Photos/video shared with permission)
@BladderCancerUK
@ScotParl
@WorldBladderCan
#BladderCancerAwareness
Prof Param Mariappan FRCS(Urol), PhD@ParamMariappan
Let’s Fight Bladder Cancer, Scotland! @BladderCancerUK @NHS_Lothian @NHS_HS #BladderCancer #BladderCancerAware
English
@AbdallaDeb @EdinSurg_BC @WghLothian @joanfundi @Yasminabugh @niyatilobo Hi Abdalla - drop me an email please: param.mariappan@nhs.scot
English
@ParamMariappan @EdinSurg_BC @WghLothian @joanfundi @Yasminabugh @niyatilobo How to register for the meeting please?
English
Just a handful of places left - come join us in Edinburgh.
Email param.mariappan@nhs.scot if keen to attend.
#TURBT
#Enbloc
#LGNMIBC
@EdinSurg_BC @WghLothian
@joanfundi @Yasminabugh @niyatilobo Eva Comperat; John McGrath; Ben Ayres; Sahar Naaseri
English
Prof Param Mariappan FRCS(Urol), PhD retweetledi
I’m helping raise money for Rosemere Cancer Foundation! Support me at: justgiving.com/page/alison-bi…
NOT TOO LATE TO DONATE.
ALL MONEY TO @RosemereCF supporting patients across #lancs #southcumbria
#walkingforjohn
#walkingformypatients
English
Prof Param Mariappan FRCS(Urol), PhD retweetledi
Great discussions here at the Masterclass on Muscle-invasive bladder cancer, April 16 & 17 in Amsterdam, the Netherlands.
It was a pleasure to reconnect with Prof. Prof Param Mariappan during the congress. #innovation #oncology #BladderEpiCheck
English
Prof Param Mariappan FRCS(Urol), PhD retweetledi
What could have been a turf war turned into something far more valuable! Our patients with #BladderCancer deserve better than siloed care after TMT. Shared surveillance and multidisciplinary counseling are the standard we should be holding ourselves to right now.
I know some of you were hoping for more fireworks at #EAU25 - May 17 might be your lucky day. 😏 @IBCG_BladderCA - @AmerUrological #BladderCancer Forum at #AUA26
@nehavapiwala Toine @ParamMariappan #EAU25 @AlisonBirtle @achoud72 @Prof_Nick_James @VedangMurthy
UroToday.com@urotoday
Managing radiation toxicity after trimodal therapy for #BladderCancer. @UroDocAsh @UTMDAnderson moderates a debate between Antoine Van Der Heijden, MD, PhD @radboudumc & @NehaVapiwala @PennMedicine. Urologists vs Radiation Oncologists, both advocate for multidisciplinary counseling and shared surveillance rather than siloed specialty management. #WatchNow > bit.ly/4tHQy5y
English
@AlexBCDNg @NIHRresearch @veerukasi @EmbertonMark @ShonitP @yipenghu @dougpendse @giga_fra @COMPASSurology @uclmedsci @UCL_ACO @ucl Many congratulations Alex - all the best!
English
🥂 Delighted to start my @NIHRresearch Doctoral Fellowship today. Real honour to receive this post-F2 & pre-training
🧬 My work will focus on optimising clinical implementation of AI in prostate MRI
🙏 Grateful to my supervisors for their guidance and mentorship
English
Prof Param Mariappan FRCS(Urol), PhD retweetledi
After all the comments on EV209 (A phase 2 study of EVPx9 without cystectomy in the cCRs in MIBC patients), we decided to make a @Uromigos podcast on it and invite some of the voices @LauraBukavinaMD @AmandaNizamMD @DrTylerStewart ⚡️🌪️👉podcasts.apple.com/us/podcast/the…
Tom Powles@tompowles1
A 240 pateint single arm trial exploring 9 cycles of EVP without planned surgery in MIBC. This will answer the key questions ‘What happens if we don’t do cystectomy in those with clinical complete response after initial EVP’.It assesses cCR rates and bladder intact EFS. It will clarify ‘EVP 1st ask questions later’ #GUtrendingTopics @OncoAlert
English
The most important step at the beginning of almost every #BladderCancer patient's pathway.
Regardless of technique, it is vital to deliver the #TURBT as a package.
@UroDocAsh
#IBCG26
#EAU26
#BAUS26
#UroSoMe
Ashish M. Kamat, MD, MBBS@UroDocAsh
Couldn’t agree more! This is why the @IBCG_BladderCA will make this one of the focus topics of our retreat this year, #IBCG26 My prior comments here (some may call it a rant!) 🤷🏻♂️ x.com/urodocash/stat… @UrogerliMD @JoshMeeks @siadaneshmand @JimCatto @RobertoContieri @paolo_gontero @ParamMariappan @joanfundi @jteoh_hk @spsutkaMD @Uromigos @LauraBukavinaMD @WesKassouf @drgaganprakash @SUO_YUO @veerukasi #EAU26
English
@EAUYAUrology @MaximeValle5 @danieleamparore @EnricoCheccucci @mwvetterlein @GMarra_MD @amorgado4 @BenjaminPradere @AngeloTerrito Keep inspiring - well done, everyone! 🌟
English
@shilpaonc @scserendipity1 @UroDocAsh @EUplatinum @EurUrolOncol @Albert0Briganti @montypal @carme_mir1 @spsutkaMD @LauraBukavinaMD Many congratulations Ashish! 👏🏾
English
Congrats @UroDocAsh on receiving the Platinum Award 2026 @EUplatinum @EurUrolOncol for your leadership & being a source of inspiration! @Albert0Briganti
@montypal @carme_mir1
English
@UroDocAsh @brookmans76 @shilpaonc @EUplatinum @EurUrolOncol @IBCG_BladderCA @ClevelandClinic Many congratulations Shilpa - so well deserved indeed !
English
Congratulations to superstar @shilpaonc on receiving the ‘Medical Oncologist Ambassador Award’ for all her work in supporting bladder cancer efforts at @EUplatinum @EurUrolOncol 🥇⭐️👏 #EAU26 @IBCG_BladderCA @ClevelandClinic
English
Prof Param Mariappan FRCS(Urol), PhD retweetledi
Join us tomorrow - Orange Area eURO Auditorium 2
Common problems and controversies in bladder cancer: Rapid-fire debates! with
@NehaVapiwala @ParamMariappan @LAUrology_NL @achoud72 @Prof_Nick_James @DrSpratticus @siadaneshmand @MRoupret @bbmdmsk @joanfundi @LauraBukavinaMD @UroMoschini @jteoh_hk @paolo_gontero @BenjaminPradere @BogdanaSchmidt @MattGalsky @tompowles1 #UroTwitter #BladderCancer #EAU26
Ashish M. Kamat, MD, MBBS@UroDocAsh
As we wrap a whirlwind of data in bladder cancer at #GU26, wishing everyone safe travels home. Rest up - London and #EAU26 are just around the corner! I'm especially excited to once again lead the "Common Problems and Controversies in Bladder Cancer: Rapid-fire Debates." Friday 13 March 10:45 - 12:15 We’ve designed this session to cut through the noise - no long lectures - just leading experts, opposing viewpoints, and the direct clinical insights you need for daily practice. It remains one of the most anticipated highlights of the meeting for a reason!
English
Prof Param Mariappan FRCS(Urol), PhD retweetledi
Efficacy means nothing if we can't get our patients to finish the course!🏁✅
Looking forward to discussing strategies to reduce toxicity, improve patient adherence, decrease dropout rates, and improve efficacy of intravesical BCG 💫
#EAU26 @ParamMariappan @niyatilobo @chats69 @IBCG_BladderCA @WorldBladderCan @UroToday #BladderCancer @UrogerliMD @MargoWickersham
English
@paolo_gontero @jteoh_hk @carme_mir1 @LAUrology_NL @ParamMariappan @MRoupret @joanfundi @DrShariat @UroMoschini @UrogerliMD @shilpaonc Poll #3: High-risk BCG naïve NMIBC: BCG + IO – Bold new standard or overreach?
@paolo_gontero @jteoh_hk @carme_mir1 @LAUrology_NL @MRoupret @joanfundi
@shilpaonc @AndreaNecchi @SpiessPhilippe @AlisonBirtle
#EAU26 #BladderCancer
Suomi
As in prior years, we will again run a series of live polls tied to the Rapid Fire Debate session at #EAU26.
There are no right answers; only your honest perspective. Your vote and comments will help drive the discussion, during the new “Presidential Debate” format introduced by @MaartenAlbersen
#UroTwitter #BladderCancer #EAU26 #GU26
Ashish M. Kamat, MD, MBBS@UroDocAsh
As we wrap a whirlwind of data in bladder cancer at #GU26, wishing everyone safe travels home. Rest up - London and #EAU26 are just around the corner! I'm especially excited to once again lead the "Common Problems and Controversies in Bladder Cancer: Rapid-fire Debates." Friday 13 March 10:45 - 12:15 We’ve designed this session to cut through the noise - no long lectures - just leading experts, opposing viewpoints, and the direct clinical insights you need for daily practice. It remains one of the most anticipated highlights of the meeting for a reason!
English
English
It’s disappointing to me that TURBT continues to be dismissed as a “low-priority” procedure in so many training programs.
This single step defines the entire course for a bladder cancer patient. Accurate diagnosis, precise staging, and the choice of therapy all hinge on a high quality TURBT.
And the “advanced genomic analysis and molecular profiling” these same programs love to promote? It all begins with adequate, high-quality tissue obtained through a TURBT.
Yet incomplete resections leave behind residual tumor in up to 78% of cases at restaging, leading to higher recurrence rates and unnecessary progression.
If we are serious about improving outcomes in NMIBC - and even MIBC - we must treat TURBT with the respect it deserves: structured, deliberate training curricula, hands-on attending involvement, and real performance metrics.
This is why the @IBCG_BladderCA will make this one of the focus topics of our retreat this year, #IBCG26
@UrogerliMD @JoshMeeks @bbmdmsk @siadaneshmand @RobertoContieri @paolo_gontero @ParamMariappan @joanfundi @jteoh_hk @spsutkaMD @WorldBladderCan @BladderCancerUS @drgaganprakash @SUO_YUO @veerukasi
English
@UroDocAsh 💯 agree. It’s vital to Get It Right First Time with the initial resection & diagnosis to reliably determine treated biological potential before any treatment, including doing nothing but surveillance.
#GIRFT
#RealisticMedicine
English
Important randomized data (JCOG1019) suggesting that in carefully selected HG T1 patients with a negative re-TUR, active surveillance may achieve comparable oncologic outcomes to BCG, with less toxicity.
Encouraging signal - especially in the era of BCG constraints
That said, selection is everything. This is not a broad replacement for BCG, but a potential option for a very defined, well-counseled group under close follow-up.
As always in #BladderCancer cancer: biology, quality of resection, and vigilance matter.
@IBCG_BladderCA @UrogerliMD @MaxKates @tompowles1 @MRoupret @JoshMeeks @joanfundi @AndreaNecchi
European Urology@EUplatinum
📢 New publication in European Urology We are pleased to highlight a new study published in European Urology, titled "Active Surveillance Versus Intravesical Bacillus Calmette-Guérin for High-grade T1 Bladder Cancer with Negative Second Transurethral Resection: The Randomized Noninferiority Phase 3 JCOG1019 Trial". 👏 Congratulations to Hiroshi Kitamura et al. on this excellent contribution, together with all co-authors. 🔗 Read the full article here: 👉 lnkd.in/ePEvrQDY #EuropeanUrology #Urology #UroOncology #Research #MedicalResearch #AcademicUrology
English
Prof Param Mariappan FRCS(Urol), PhD retweetledi
🚨JUST RELEASED!
📺Watch the discussion with @UroDocAsh on our publication at @EurUrolOncol, posted by @urotoday
🎙️We speak about the definition of cure in #bladdercancer
🔗tinyurl.com/mwb972az
Félix Guerrero-Ramos@DrFelixGuerrero
❓How to define #cure in localized #bladdercancer? 🥸Check out our #systematicreview on this hot topic just published in @EurUrolOncol 🔗t.ly/tz16i @dralvaropinto @H12Octubre @bvh12o @Uroweb @GuardConsortium @IBCG_BladderCA @UroDocAsh @MRoupret @jteoh_hk @CANVES_ES
Cota, Colombia 🇨🇴 English